HEALTHCARE
Global Intrauterine Devices Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global Intrauterine Devices Market, By Type (Hormonal Intrauterine Device and Copper Intrauterine Device), Age Group (25-34 years, 35-44 years, Above 44 years, 15-24 years), Product Type (Mirena, Skyla, Paragard, Essure, Levosert, Others), End User (Hospitals, Gynecology Clinics, Community Health Care Centers, Others), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
The global intrauterine devices market size is valued to be USD xx million in 2023 and is expected to reach USD xx million by 2032, and it is expected to register a CAGR of xx% over the forecast period 2024-2032.
Intrauterine Devices (IUDs) are small, T-shaped contraceptive devices that are put into the uterus to avoid pregnancy. These can be hormonal or non-hormonal; hormonal IUDs work by releasing progestin to prevent ovulation and thicken cervical mucus; non-hormonal IUDs, which are frequently composed of copper, work by making an unfavorable environment for sperm. The IUD is a long-term, very efficient method of contraception that needs minimal maintenance. The Intrauterine Devices Market comprises IUD production, distribution, and consumption around the globe. This market comprises important players like manufacturers, suppliers, healthcare providers, and end users and covers several types of IUDs, such as hormonal and copper-based devices. The development of IUD technology and rising awareness of long-term contraception are the main drivers of market expansion.
The respective global report analyses market trends, consumer behaviour and industry dynamics to guide towards entry into new markets with ease. Also, it assists in tailoring market specific and related products and services to meet the needs, preferences, and expectations of target audience by delving into their psychology. The report also specializes with comprehensive and extensive competitive analysis which offers useful insights into competitor strengths, weaknesses, opportunities, and threats. The respective report offers exclusive insights into the potential impact of disruptive developments and technologies that are expected to completely transform corporate operations. The context includes tailor-made research solutions to create a stronger footprint in their particular industries thereby offering dedicated customized solutions according to the client needs which helps in addressing unique business challenges with more simplified and efficient decision-making solutions.
Market Dynamics
DRIVERS
- Growing demand for effective contraceptive options.
- Increased focus on family planning and population control.
RESTRAINTS
- Cultural and societal resistance to contraceptive use.
- Potential side effects and discomfort associated with IUDs
OPPORTUNITIES
- Expansion into emerging markets with rising healthcare access.
- Innovation in IUD technology to enhance user comfort and effectiveness.
CHALLENGES
- Competition from other contraceptive methods.
- Regulatory hurdles and varying approval processes in different countries.
SEGMENTATION
- Type
- Hormonal Intrauterine Device
- Copper Intrauterine Device
- Age Group
- 25-34 years
- 35-44 years
- Above 44 years
- 15-24 years
- Product Type
- Mirena
- Skyla
- Paragard
- Essure
- Levosert
- Others
- End User
- Hospitals
- Gynecology Clinics
- Community Health Care Centers
- Others
The respective global report is completely customizable specific to regions (North America, Europe, Asia-Pacific, South America, Middle East and Africa), countries, and segments as per the client requirements.
REGIONAL SEGMENTATION
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- Teva Pharmaceutical Industries Ltd.
- Bayer
- EUROGINE
- CooperSurgical Inc.
- Pfizer Inc.
- HLL Lifecare Limited
- OCON Medical Ltd.
- Prosan International BV
- Melbea Innovations
- Allergan
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global Intrauterine Devices Market, by Type
- 3.2 Global Intrauterine Devices Market, by Age Group
- 3.3 Global Intrauterine Devices Market, by Product Type
- 3.4 Global Intrauterine Devices Market, by End User
- 3.5 Global Intrauterine Devices Market, by Geography
- 3.6 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Growing preference for non-hormonal IUDs.
- 5.1.2 Technological advancements improving device design and safety.
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Growing demand for effective contraceptive options.
- 5.2.2 Increased focus on family planning and population control.
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 Cultural and societal resistance to contraceptive use.
- 5.3.2 Potential side effects and discomfort associated with IUDs.
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Expansion into emerging markets with rising healthcare access.
- 5.4.2 Innovation in IUD technology to enhance user comfort and effectiveness.
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Competition from other contraceptive methods.
- 5.5.2 Regulatory hurdles and varying approval processes in different countries.
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL INTRAUTERINE DEVICES MARKET, BY TYPE
- 6.1 Type Summary
- 6.2 Market Attractive Index
- 6.3 Global Intrauterine Devices Market, by Type (2019-2032)
- SECTION 7 - GLOBAL INTRAUTERINE DEVICES MARKET, BY AGE GROUP
- 7.1 Age Group Summary
- 7.2 Market Attractive Index
- 7.3 Global Intrauterine Devices Market, by Age Group (2019-2032)
- SECTION 8 - GLOBAL INTRAUTERINE DEVICES MARKET, BY PRODUCT TYPE
- 8.1 Product Type Summary
- 8.2 Market Attractive Index
- 8.3 Global Intrauterine Devices Market, by Product Type (2019-2032)
- SECTION 9 - GLOBAL INTRAUTERINE DEVICES MARKET, BY END USER
- 9.1 End User Summary
- 9.2 Market Attractive Index
- 9.3 Global Intrauterine Devices Market, by End User (2019-2032)
- SECTION 10 - GLOBAL INTRAUTERINE DEVICES MARKET, BY GEOGRAPHY
- 10.1 Regional Summary
- 10.2 Market Attractive Index
- 10.3 Global Intrauterine Devices Market, by Geography (2019-2032)
- SECTION 11 - NORTH AMERICA INTRAUTERINE DEVICES MARKET
- 11.1 North America Summary
- 11.2 Market Attractive Index
- 11.3 North America Intrauterine Devices Market, by Type (2019-2032)
- 11.4 North America Intrauterine Devices Market, by Age Group (2019-2032)
- 11.5 North America Intrauterine Devices Market, by Product Type (2019-2032)
- 11.6 North America Intrauterine Devices Market, by End User (2019-2032)
- 11.7 North America Intrauterine Devices Market, by Country (2019-2032)
- 11.7.1 U.S.
- 11.7.2 Canada
- 11.7.3 Mexico
- 11.7.4 Rest of North America
- SECTION 12 - EUROPE INTRAUTERINE DEVICES MARKET
- 12.1 Europe Summary
- 12.2 Market Attractive Index
- 12.3 Europe Intrauterine Devices Market, by Type (2019-2032)
- 12.4 Europe Intrauterine Devices Market, by Age Group (2019-2032)
- 12.5 Europe Intrauterine Devices Market, by Product Type (2019-2032)
- 12.6 Europe Intrauterine Devices Market, by End User (2019-2032)
- 12.7 Europe Intrauterine Devices Market, by Country (2019-2032)
- 12.7.1 Germany
- 12.7.2 U.K.
- 12.7.3 France
- 12.7.4 Italy
- 12.7.5 Spain
- 12.7.6 Russia
- 12.7.7 The Netherlands
- 12.7.8 Belgium
- 12.7.9 Turkey
- 12.7.10 Rest of Europe
- SECTION 13 - ASIA-PACIFIC INTRAUTERINE DEVICES MARKET
- 13.1 Asia-Pacific Summary
- 13.2 Market Attractive Index
- 13.3 Asia-Pacific Intrauterine Devices Market, by Type (2019-2032)
- 13.4 Asia-Pacific Intrauterine Devices Market, by Age Group (2019-2032)
- 13.5 Asia-Pacific Intrauterine Devices Market, by Product Type (2019-2032)
- 13.6 Asia-Pacific Intrauterine Devices Market, by End User (2019-2032)
- 13.7 Asia-Pacific Intrauterine Devices Market, by Country (2019-2032)
- 13.7.1 China
- 13.7.2 India
- 13.7.3 Japan
- 13.7.4 South Korea
- 13.7.5 Singapore
- 13.7.6 Malaysia
- 13.7.7 Australia
- 13.7.8 Thailand
- 13.7.9 Philippines
- 13.7.10 Rest of Asia-Pacific
- SECTION 14 - SOUTH AMERICA INTRAUTERINE DEVICES MARKET
- 14.1 South America Summary
- 14.2 Market Attractive Index
- 14.3 South America Intrauterine Devices Market, by Type (2019-2032)
- 14.4 South America Intrauterine Devices Market, by Age Group (2019-2032)
- 14.5 South America Intrauterine Devices Market, by Product Type (2019-2032)
- 14.6 South America Intrauterine Devices Market, by End User (2019-2032)
- 14.7 South America Intrauterine Devices Market, by Country (2019-2032)
- 14.7.1 Brazil
- 14.7.2 Argentina
- 14.7.3 Chile
- 14.7.4 Colombia
- 14.7.5 Rest of South America
- SECTION 15 - MIDDLE EAST AND AFRICA INTRAUTERINE DEVICES MARKET
- 15.1 Middle East and Africa Summary
- 15.2 Market Attractive Index
- 15.3 Middle East and Africa Intrauterine Devices Market, by Type (2019-2032)
- 15.4 Middle East and Africa Intrauterine Devices Market, by Age Group (2019-2032)
- 15.5 Middle East and Africa Intrauterine Devices Market, by Product Type (2019-2032)
- 15.6 Middle East and Africa Intrauterine Devices Market, by End User (2019-2032)
- 15.7 Middle East and Africa Intrauterine Devices Market, by Country (2019-2032)
- 15.7.1 Kingdom of Saudi Arabia
- 15.7.2 South Africa
- 15.7.3 U.A.E.
- 15.7.4 Egypt
- 15.7.5 Rest of Middle East and Africa
- SECTION 16 - COMPANY SHARE ANALYSIS
- 16.1 Global Intrauterine Devices Market, Company Share Analysis
- 16.2 North America Intrauterine Devices Market, Company Share Analysis
- 16.3 Europe Intrauterine Devices Market, Company Share Analysis
- 16.4 Asia-Pacific Intrauterine Devices Market, Company Share Analysis
- SECTION 17 - COMPANY PROFILES
- 17.1 Teva Pharmaceutical Industries Ltd.
- 17.1.1 Company Snapshot
- 17.1.2 Financial Overview
- 17.1.3 Product Portfolio
- 17.1.4 Recent Developments
- 17.2 Bayer
- 17.2.1 Company Snapshot
- 17.2.2 Financial Overview
- 17.2.3 Product Portfolio
- 17.2.4 Recent Developments
- 17.3 EUROGINE
- 17.3.1 Company Snapshot
- 17.3.2 Financial Overview
- 17.3.3 Product Portfolio
- 17.3.4 Recent Developments
- 17.4 CooperSurgical Inc.
- 17.4.1 Company Snapshot
- 17.4.2 Financial Overview
- 17.4.3 Product Portfolio
- 17.4.4 Recent Developments
- 17.5 Pfizer Inc.
- 17.5.1 Company Snapshot
- 17.5.2 Financial Overview
- 17.5.3 Product Portfolio
- 17.5.4 Recent Developments
- 17.6 HLL Lifecare Limited
- 17.6.1 Company Snapshot
- 17.6.2 Financial Overview
- 17.6.3 Product Portfolio
- 17.6.4 Recent Developments
- 17.7 OCON Medical Ltd.
- 17.7.1 Company Snapshot
- 17.7.2 Financial Overview
- 17.7.3 Product Portfolio
- 17.7.4 Recent Developments
- 17.8 Prosan International BV
- 17.8.1 Company Snapshot
- 17.8.2 Financial Overview
- 17.8.3 Product Portfolio
- 17.8.4 Recent Developments
- 17.9 Melbea Innovations
- 17.9.1 Company Snapshot
- 17.9.2 Financial Overview
- 17.9.3 Product Portfolio
- 17.9.4 Recent Developments
- 17.10 Allergan
- 17.10.1 Company Snapshot
- 17.10.2 Financial Overview
- 17.10.3 Product Portfolio
- 17.10.4 Recent Developments
- SECTION 18 - RELATED REPORTS
- SECTION 19 - DISCLAIMER
RESEARCH METHODOLOGY
The research methodology employed in Uniprism Market Research involves four basic steps namely research and data collection, data pre-processing, modeling and forecasting, quality assurance and output.
RESEARCH AND DATA COLLECTION
A tripod model research technique is followed for research and data collection in which various approaches such as primary research, secondary research, and product mapping are considered.
Primary research basically involves the process of conducting personalized interviews with market related professionals of major market players, investors, distributors, vendors and many more.
The secondary research include data published by government, annual reports, press releases, investor presentations of companies, white papers, certified publications, annual manufacturing limit of the respective industries related to the market, production consumption analysis of certain products respective to the market and many more.
Below mention are few of the sources which we have considered while estimating the market size:
For instance,
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
Product mapping means the process of mapping the list of products that a key player contributes to the market as well as estimating the revenue of those products in order to define the Global Company share analysis of the respective Global Company in global, regional, and country level markets.
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
The process of developing mathematical, statistical, or computational representations of real-world occurrences or relationships is known as modelling. These models are intended to replicate and explain market interactions, interdependence, and dynamics. These models are used by Uniprism Market Research to acquire a better knowledge of numerous market characteristics such as customer preferences, pricing elasticity, competition dynamics, and more. Depending on the individual study aims, many types of models are utilized, such as regression models, econometric models, decision tree models, and machine learning models.
Forecasting is the process of predicting future market conditions, trends, and occurrences using past data and models. Forecasting is used by Uniprism Market Research to estimate future sales, demand for products or services, market growth, and other important performance metrics. Forecasting accurately can assist organizations in making educated decisions about resource allocation, pricing, inventory management, and marketing tactics.
We create standardized bottom-up or top-down models that scale by leveraging data science and machine learning technology. All our market models consider the unique market characteristics of each country. Forecasting is based on major market indicators and a combination of traditional methodologies, such as exponential smoothing, time series analysis, regression analysis, and more modern techniques such as machine learning algorithms are all forecasting methodologies. The method chosen is determined on the nature of the data and the specific forecasting aims.
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.